Rectal stage 0 and I

Stage 0 or carcinoma in situ (Ts, N0,M0)

Surgery to remove the cancerous tissue and surrounding healthy margins including:

Followup

If pathology reports show that the polyp or lesion was completely removed, margins are clear of cancer cells, and there are no unfavorable signs, then watching carefully for possible recurrence is appropriate.

If the lesions were not completely removed, cancer cells remain in the margins, or the tumor extends farther than the inner lining of the rectum (T1), then additional surgery is recommended.

Stage I (T1 or T2,N0,M0)

The tumor is limited to the inner three layers of the rectum but has not spread outside its wall, lymph nodes show no sign of being involved, and there is no sign that cancer has spread beyond the rectum.

Surgery

Adjuvant treatment after surgery

Follow-up (adjuvant) treatment depends on what the pathologist finds when the surgical specimen is examined.

After transanal local excision

If the tumor is confined to the inner walls of the rectum (T1), margins are clear, and there are no high risk features, patients can be observed with follow-up surveillence.

If there are signs that that recurrence is more likely, a second operation through the abdomen (LAR or APR) may be called for.  High risk signs include:

After abdominal surgery

If pathology shows that the cancer remains Stage I (T1 or T2 with no spread to lymph nodes or distant sites), observation with follow-up surveillance is appropriate.

If the tumor has gone through the outer layer of the rectum (T3) or there are cancer cells in lymph nodes (N1 or N2) then follow-up chemotherapy and chemoradiation may be recommended.  Adjuvant treatment is usually a “sandwich” of chemotherapy, chemoradiation, and additional chemotherapy.

Where Can You Go for More Information

NCI Rectal Cancer Treatment by Stage

Last Update: June 29, 2008

Medical Review
This page is under review by C3's medical review network.

Search C3

Colorectal Cancer Action Center

Your voice makes a difference. Join us.

Sign Up Now

Subscribe to the C3 website

Get C3 news & updates

Get the latest articles in your email inbox or news reader as soon as they are published.

Subscribe